Bionano Genomics, Inc. Restricted Cash, Current
Bionano Genomics, Inc. (BNGO) had Restricted Cash, Current of $11.01 million as of 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashCurrent · last filed 2024-08-07
- 2024-06-30: Restricted Cash, Current $11.01M.
- 2023-12-31: Restricted Cash, Current $0.00.
| Period end | Restricted Cash, Current |
|---|---|
| 2024-06-30 | $11.01M 10-Q · filed 2024-08-07 |
| 2023-12-31 | $0.00 10-Q · filed 2024-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |